Globus Medical Cash Flow Conversion Efficiency
Globus Medical cash flow conversion efficiency. Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.086x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($412.11 Million) by net assets ($4.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Globus Medical (2010–2025)
Cash flow conversion efficiency of Globus Medical from 2010 to 2025. This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Globus Medical (GMED) share price today for real-time trading data and today's change.
Globus Medical Cash Flow Conversion Ratio Explained
Globus Medical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Globus Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency. Also see GMED market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Baloise Holding AG
SW:BALN
|
0.211x |
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
-0.079x |
|
Voya Financial Inc
NYSE:VOYA
|
-0.418x |
|
Sirius XM Holding Inc
NASDAQ:SIRI
|
0.023x |
|
thyssenkrupp AG
XETRA:TKA
|
-0.120x |
|
The Federal Bank Limited
NSE:FEDERALBNK
|
-0.058x |
|
Banca Transilvania S.A.
RO:TLV
|
0.028x |
|
Li Auto Inc
NASDAQ:LI
|
0.000x |
Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2025)
The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2025. Review Globus Medical free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.57 Billion | $753.45 Million | 0.165x | +32.19% |
| 2024-12-31 | $4.18 Billion | $520.64 Million | 0.125x | +104.63% |
| 2023-12-31 | $4.00 Billion | $243.50 Million | 0.061x | -36.99% |
| 2022-12-31 | $1.85 Billion | $178.47 Million | 0.097x | -39.07% |
| 2021-12-31 | $1.74 Billion | $276.27 Million | 0.159x | +20.21% |
| 2020-12-31 | $1.51 Billion | $198.79 Million | 0.132x | +7.63% |
| 2019-12-31 | $1.40 Billion | $171.97 Million | 0.123x | -19.97% |
| 2018-12-31 | $1.19 Billion | $181.64 Million | 0.153x | -7.05% |
| 2017-12-31 | $967.78 Million | $159.53 Million | 0.165x | -20.20% |
| 2016-12-31 | $832.08 Million | $171.89 Million | 0.207x | +21.17% |
| 2015-12-31 | $715.32 Million | $121.96 Million | 0.170x | +26.07% |
| 2014-12-31 | $585.45 Million | $79.17 Million | 0.135x | -31.66% |
| 2013-12-31 | $472.36 Million | $93.47 Million | 0.198x | -0.05% |
| 2012-12-31 | $386.50 Million | $76.52 Million | 0.198x | -26.81% |
| 2011-12-31 | $282.48 Million | $76.41 Million | 0.271x | -13.41% |
| 2010-12-31 | $228.19 Million | $71.29 Million | 0.312x | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more